Academic Journal
Establishing mRNA and microRNA interactions driving disease heterogeneity in amyotrophic lateral sclerosis patient survival
العنوان: | Establishing mRNA and microRNA interactions driving disease heterogeneity in amyotrophic lateral sclerosis patient survival |
---|---|
المؤلفون: | Waller, Rachel, Bury, Joanna J, Appleby-Mallinder, Charlie, Wyles, Matthew, Loxley, George, Babel, Aditi, Shekari, Saleh, Kazoka, Mbombe, Wollff, Helen, Al-Chalabi, Ammar, Heath, Paul R, Shaw, Pamela J, Kirby, Janine |
المساهمون: | EuroMOTOR, Seventh Framework Health Cooperation Programme, Amyotrophic Lateral Sclerosis, Motor Neurone Disease Association, MNDA, Wellcome Trust, National Motor Neuron Disease DNA Bank, Motor Neuron Disease Association, National Institute for Health and Care Research, NIHR, Sheffield Biomedical Research Centre |
المصدر: | Brain Communications ; volume 6, issue 1 ; ISSN 2632-1297 |
بيانات النشر: | Oxford University Press (OUP) |
سنة النشر: | 2023 |
الوصف: | Amyotrophic lateral sclerosis is a fatal neurodegenerative disease, associated with the degeneration of both upper and lower motor neurons of the motor cortex, brainstem and spinal cord. Death in most patients results from respiratory failure within 3–4 years from symptom onset. However, due to disease heterogeneity some individuals survive only months from symptom onset while others live for several years. Identifying specific biomarkers that aid in establishing disease prognosis, particularly in terms of predicting disease progression, will help our understanding of amyotrophic lateral sclerosis pathophysiology and could be used to monitor a patient’s response to drugs and therapeutic agents. Transcriptomic profiling technologies are continually evolving, enabling us to identify key gene changes in biological processes associated with disease. MicroRNAs are small non-coding RNAs typically associated with regulating gene expression, by degrading mRNA or reducing levels of gene expression. Being able to associate gene expression changes with corresponding microRNA changes would help to distinguish a more complex biomarker signature enabling us to address key challenges associated with complex diseases such as amyotrophic lateral sclerosis. The present study aimed to investigate the transcriptomic profile (mRNA and microRNA) of lymphoblastoid cell lines from amyotrophic lateral sclerosis patients to identify key signatures that are distinguishable in those patients who suffered a short disease duration (<12 months) (n = 22) compared with those that had a longer disease duration (>6 years) (n = 20). Transcriptional profiling of microRNA–mRNA interactions from lymphoblastoid cell lines in amyotrophic lateral sclerosis patients revealed differential expression of genes involved in cell cycle, DNA damage and RNA processing in patients with longer survival from disease onset compared with those with short survival. Understanding these particular microRNA–mRNA interactions and the pathways in ... |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1093/braincomms/fcad331 |
DOI: | 10.1093/braincomms/fcad331/54092489/fcad331.pdf |
الاتاحة: | http://dx.doi.org/10.1093/braincomms/fcad331 https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcad331/54092489/fcad331.pdf https://academic.oup.com/braincomms/article-pdf/6/1/fcad331/56688778/fcad331.pdf |
Rights: | https://creativecommons.org/licenses/by/4.0/ |
رقم الانضمام: | edsbas.1B4825C6 |
قاعدة البيانات: | BASE |
DOI: | 10.1093/braincomms/fcad331 |
---|